Adagio Medical Holdings, Inc.
ADGMNasdaq
$0.53
0.0%Jul 17 close · end-of-day
Price
1Y↓ -63.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$11.8M
Enterprise Value
$21.7M
P/E
—
P/S
—
P/B
2.1
EV/EBITDA
—
PEG
—
FCF Yield
-135.7%
Dividend Yield
—
Revenue (TTM)
—
Net Income (TTM)
-$24.4M
Free Cash Flow (TTM)
-$16.0M
Gross Margin
—
Operating Margin
—
Net Margin
—
ROE
-425.6%
ROIC
-99.2%
Debt / Equity
4.0
Net Cash
-$10.0M
Return 1Y
-64.7%
Company profile
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Headquarters
- California
Management & directors
- Kaster DeborahChief Financial Officer
- Usen ToddChief Executive Officer
Roles derived from SEC Form 4 filings.
Earnings
ADGM Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$0.00—
Diluted EPS-$0.31↓ -39.2%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenue | $300,000.00 | — | $0.00 |
| Gross profit | — | — | — |
| Operating income | -$27.9M | — | -$21.9M |
| Net income | -$36.6M | — | -$25.1M |
| Diluted EPS | -$48.16 | — | -$1.51 |
| Operating cash flow | -$25.7M | — | -$19.0M |
| Free cash flow | -$26.0M | — | -$19.4M |
| Gross margin | — | — | — |
| Operating margin | -9314.0% | — | — |
| Net margin | -12196.7% | — | — |
| Line item | Q2 '24 | Q3 '24 | Q '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $254,000.00 | $132,000.00 | $137,000.00 | $0.00 | — | $0.00 | — | $0.00 |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | -$6.7M | -$4.4M | -$58.1M | -$7.4M | -$4.7M | -$5.7M | -$4.1M | -$5.2M |
| Net income | -$5.7M | $3.6M | -$57.4M | -$7.7M | -$3.9M | -$10.1M | -$3.3M | -$7.0M |
| Diluted EPS | -$7.35 | $0.02 | -$3.72 | -$0.51 | -$0.35 | -$0.66 | $0.01 | -$0.31 |
| Operating cash flow | -$6.9M | -$6.4M | -$7.1M | -$7.2M | -$4.7M | -$3.0M | -$4.1M | -$4.1M |
| Free cash flow | -$7.1M | -$6.9M | -$7.8M | -$7.5M | -$4.7M | -$3.5M | -$4.6M | -$4.1M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | -2621.7% | -3352.3% | -42375.9% | — | — | — | — | — |
| Net margin | -2257.5% | 2731.8% | -41902.2% | — | — | — | — | — |
Company news
May 12, 2026
Apr 29, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2025-12-16 | Kaster Deborah· Chief Financial Officer | Buy | 15,000 | $1.20 | $17,973.00 | filing |
| 2025-12-12 | Usen Todd· Chief Executive Officer | Buy | 207,315 | $1.09 | $225,973.35 | filing |
Latest 2 transactions.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.